# Bicarbonate for In-Hospital Cardiac Arrest

Study · id `cardio:ct-nct05564130` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05564130](<https://clinicaltrials.gov/study/NCT05564130>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05564130

Browse, organ or system: Heart  
Browse, condition area: Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 778 participants.

## Technical summary

Registry record NCT05564130. Randomized; quadruple masking; primary purpose treatment. Start 2023-02-06 (actual); primary completion 2026-02-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 778 participants (planned count; ClinicalTrials.gov record NCT05564130, source copy `cardio:ctgov-nct05564130-2026-02-17`, retrieved 2026-10-26)
- Started: 2023-02-06 (actual) (ClinicalTrials.gov record NCT05564130, source copy `cardio:ctgov-nct05564130-2026-02-17`, retrieved 2026-10-26)
- Primary completion: 2026-02-11 (actual) (ClinicalTrials.gov record NCT05564130, source copy `cardio:ctgov-nct05564130-2026-02-17`, retrieved 2026-10-26)
- Completion: 2027-02-11 (anticipated) (ClinicalTrials.gov record NCT05564130, source copy `cardio:ctgov-nct05564130-2026-02-17`, retrieved 2026-10-26)
- Countries: Denmark (ClinicalTrials.gov record NCT05564130, source copy `cardio:ctgov-nct05564130-2026-02-17`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05564130-2026-02-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: Bicarbonate for In-Hospital Cardiac Arrest
- Acronym: BIHCA
- Condition: Cardiac Arrest
- Intervention (Drug): Sodium bicarbonate
- Intervention (Drug): Sodium chloride
- Lead sponsor: Lars Wiuff Andersen
- Lead sponsor class: OTHER
- Collaborator: University of Aarhus
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)
- Registry lists this organization as the lead sponsor: Lars Wiuff Andersen (`cardio:org-lars-wiuff-andersen`)
- Registry lists this organization as a collaborator: University of Aarhus (`cardio:org-university-of-aarhus`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Sodium Bicarbonate for In-Hospital Cardiac Arrest: A Randomized Clinical Trial (`cardio:pubmed-42273960`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 04fd15d69e893ac91edb4e65a0a4715b397d00185597b29a920570c133c2ae03
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
